GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
E

Er Therapeutics PNGM · USD

N/A · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 30 Oct 2026, in USD

Price performance

Chart by TradingView, with its own licensed prices

Er Therapeutics — daily PNGM Delayed
Market value
$5,479
Last close × shares
Volume
1k
Shares, 30 Oct 2026

About Er Therapeutics

Its shares trade under the ticker PNGM. It has been listed since 10 August 2007.

Pengram Corp. engages in the acquisition, exploration and development of zinc, lead, vanadium, and galena. The company is headquartered in Bellingham, Washington. The company went IPO on 2007-08-10. The firm has not realized any revenues from its planned operations. The firm is engaged in acquiring exploration and development of natural resource properties. The firm has not commenced business operations. The firm has interests in Clisbako claims and Eureka claims. The firm has 100% interest in a group of ten mineral claims, collectively known as the Clisbako claims, which are located in the Cariboo Mining Division of British Columbia, Canada. The firm also has 100% interest in a series of mineral claims referred to as the CPG Project, Fish Claims and The Golden Snow Property, collectively known as the Eureka claims, which are situated in the Eureka County, Esmeralda County and Mineral County, Nevada.

Figures and description from our data supplier, not checked against the company's own report.

More about Er Therapeutics →

Latest on Er Therapeutics

Our reporting

We have not reported on Er Therapeutics yet.

Other N/A listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Er Therapeutics's ticker?

Er Therapeutics trades as PNGM on its US listing, under ISIN US7070622045.

What was Er Therapeutics's last closing price?

0.00 on 30 Oct 2026. The figure is in USD and is never converted.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.